Synopsis
Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cleocin Phosphate
2. Clindamycin-2-phosphate
3. Clindesse
4. Clindets
1. 24729-96-2
2. Cleocin Phosphate
3. Clindamycin 2-phosphate
4. Clindets
5. Cleocin T
6. Clindagel
7. Clindesse
8. Evoclin
9. Clinda-derm
10. Dalacin P
11. Clindamycin-2-phosphate
12. Clindamycin 2-dihydrogen Phosphate
13. Clindamycin (phosphate)
14. Dalacin T
15. 7(s)-chloro-7-deoxylincomycin 2-phosphate
16. U 28508
17. U-28508
18. U-28,508
19. Eh6d7113i8
20. Nsc 618653
21. Nsc-618653
22. Dsstox_cid_28603
23. Dsstox_rid_82873
24. Dsstox_gsid_48677
25. [(2r,3r,4s,5r,6r)-6-[(1s,2s)-2-chloro-1-[[(2s,4r)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] Dihydrogen Phosphate
26. Clindamax
27. Evoclin (tn)
28. Dalacin-s (tn)
29. Clindamycin Injection
30. Cas-24729-96-2
31. Einecs 246-433-0
32. Clindamycin Phosphate Hydrate [jan]
33. Clindamycin Dihydrogenphosphat
34. Clinadac
35. Unii-eh6d7113i8
36. Clindamycin Phosphate Hydrate
37. Clindamycin Phosphate In Dextrose 5%
38. Clindamycin-2-dihydrogenphosphat
39. Ncgc00163494-01
40. Ncgc00166320-01
41. Clindamycin-phosphate
42. Clindac
43. Xaciato
44. Clindamycin Phosphate [usan:usp:jan]
45. Cleocin Phosphate In Dextrose 5% In Plastic Container
46. Clindamycin Phosphate In Dextrose 5% In Plastic Container
47. Schembl37148
48. Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-alpha-d-galacto-octopyranoside 2-(dihydrogen Phosphate)
49. Chembl3184512
50. Dtxsid1048677
51. Bdbm241975
52. Clindamycin (as Phosphate)
53. Clindamycin Phosphate (jp17/usp)
54. Clindamycin Phosphate [jan]
55. Hy-b1064
56. Zinc4102185
57. Clindamycin Phosphate [usan]
58. Tox21_113055
59. Tox21_113410
60. Clindamycin Phosphate (u-28508e)
61. Clindamycin Phosphate [vandf]
62. Mfcd11982855
63. S2048
64. Clindamycin Phosphate [mart.]
65. Akos008901431
66. Clindamycin Phosphate [usp-rs]
67. Clindamycin Phosphate [who-dd]
68. Clindamycin Phosphate [who-ip]
69. Ccg-269736
70. Clindamycin Phosphate System Suitability
71. Cs-4620
72. Ncgc00386379-01
73. As-12554
74. L-threo-alpha-d-galacto-octapyranoside, Methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen Phosphate), (2s-trans)-
75. Methyl (2s-trans)-7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-l-threo-alpha-d-galacto-octopyranoside, 2-(dihydrogen Phosphate)
76. Clindamycin Phosphate [orange Book]
77. Duac Component Clindamycin Phosphate
78. Clindamycin Phosphate [ep Monograph]
79. Clindamycin Phosphate For System Suitability
80. Ziana Component Clindamycin Phosphate
81. Acanya Component Clindamycin Phosphate
82. Clindamycin Phosphate [usp Monograph]
83. Clindamycini Phosphas [who-ip Latin]
84. Veltin Component Clindamycin Phosphate
85. Clindamycin Phosphate Component Of Duac
86. Benzaclin Component Clindamycin Phosphate
87. Clindamycin 2-dihydrogen Phosphate [mi]
88. Clindamycin Phosphate Component Of Ziana
89. D01073
90. Idp-126 Component Clindamycin Phosphate
91. Ab01566857_01
92. Clindamycin Phosphate Component Of Acanya
93. Clindamycin Phosphate Component Of Veltin
94. A817470
95. Clindamycin Phosphate Component Of Benzaclin
96. Sr-01000872581
97. Sr-01000872581-1
98. Brd-k27771035-001-02-5
99. Q27106184
100. Clindamycin Phosphate System Suitability [usp-rs]
101. (2r,3r,4s,5r,6r)-6-((1s,2s)-2-chloro-1-((2s,4r)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2h-pyran-3-yl Dihydrogen Phosphate
102. (2r,3r,4s,5r,6r)-6-((1s,2s)-2-chloro-1-((2s,4r)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2h-pyran-3-yldihydrogenphosphate
103. (2s-trans)-methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-l-threo-.alpha.-d-galacto-octopyranoside 2-(dihydrogen Phosphate)
104. [(2r,3r,4s,5r,6r)-6-[(1s,2s)-2-chloro-1-[[(2s,4r)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] Dihydrogen Phosphate
105. [(2r,4r,5r)-6-[(2s)-2-chloro-1-[[[(2s,4r)-1-methyl-4-propyl-2-pyrrolidinyl]-oxomethyl]amino]propyl]-4,5-dihydroxy-2-(methylthio)-3-oxanyl] Dihydrogen Phosphate
106. L-threo-.alpha.-d-galacto-octopyranoside, Methyl 7-chloro-6,7,8-trideoxy-6-((((2s,4r)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen Phosphate)
107. L-threo-.alpha.-d-galacto-octopyranoside, Methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen Phosphate), (2s-trans)-
108. Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-.alpha.-d-galacto-octopyranoside 2-(dihydrogen Phosphate)
| Molecular Weight | 505.0 g/mol |
|---|---|
| Molecular Formula | C18H34ClN2O8PS |
| XLogP3 | -1.2 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 9 |
| Exact Mass | 504.1462019 g/mol |
| Monoisotopic Mass | 504.1462019 g/mol |
| Topological Polar Surface Area | 174 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 658 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 12 | |
|---|---|
| Drug Name | Cleocin phosphate |
| Drug Label | CLEOCIN PHOSPHATE Sterile Solution in vials contains clindamycin phosphate, a water soluble ester of clindamycin and phosphoric acid. Each mL contains the equivalent of 150 mg clindamycin, 0.5 mg disodium edetate and 9.45 mg benzyl alcohol added as p... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 150mg base/ml |
| Market Status | Prescription |
| Company | Pharmacia And Upjohn |
| 2 of 12 | |
|---|---|
| Drug Name | Cleocin t |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Gel; Lotion; Solution |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Pharmacia And Upjohn |
| 3 of 12 | |
|---|---|
| Drug Name | Clindagel |
| Drug Label | Clindagel (clindamycin phosphate gel) topical gel, 1%, a topical antibiotic, contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per gram in a gel vehicle consisting of carbomer 941, methylparaben, polyethylene g... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Gel |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Precision Dermat |
| 4 of 12 | |
|---|---|
| Drug Name | Clindamycin phosphate |
| PubMed Health | Clindamycin (Injection) |
| Drug Classes | Antibiotic, Antimalarial |
| Drug Label | Clindamycin Injection, USP, a water soluble ester of clindamycin and phosphoric acid, is a sterile solution for intramuscular or intravenous use.May contain sodium hydroxide and/or hydrochloric acid for pH adjustment. pH is 6.5 range 5.5to 7.0.Clin... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Lotion; Gel; Swab; Injectable; Cream; Aerosol, foam; Solution |
| Route | Topical; Injection; Vaginal |
| Strength | eq 1% base; 1%; eq 150mg base/ml; eq 2% base |
| Market Status | Prescription |
| Company | Wockhardt; Sagent Strides; Bedford; Fougera Pharms; Fresenius Kabi Usa; Hospira; Hikma Maple; Versapharm; Perrigo Uk Finco; Perrigo New York; Taro Pharm Inds; Fougera; G And W Labs |
| 5 of 12 | |
|---|---|
| Drug Name | Clindesse |
| Drug Label | CLEOCIN T Topical Solution and CLEOCIN T Topical Lotion contain clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. CLEOCIN T Topical Gel contains clindamycin phosphate, USP, at a concentration equivalent to... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Cream |
| Route | Vaginal |
| Strength | eq 2% base |
| Market Status | Prescription |
| Company | Lumara Health |
| 6 of 12 | |
|---|---|
| Drug Name | Clindets |
| Drug Label | Clindamycin phosphate, a lincosamide, is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. The chemical name for clindamycin phosphate is meth... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Swab |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Perrigo |
| 7 of 12 | |
|---|---|
| Drug Name | Cleocin phosphate |
| Drug Label | CLEOCIN PHOSPHATE Sterile Solution in vials contains clindamycin phosphate, a water soluble ester of clindamycin and phosphoric acid. Each mL contains the equivalent of 150 mg clindamycin, 0.5 mg disodium edetate and 9.45 mg benzyl alcohol added as p... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Injectable |
| Route | Injection |
| Strength | eq 150mg base/ml |
| Market Status | Prescription |
| Company | Pharmacia And Upjohn |
| 8 of 12 | |
|---|---|
| Drug Name | Cleocin t |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Gel; Lotion; Solution |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Pharmacia And Upjohn |
| 9 of 12 | |
|---|---|
| Drug Name | Clindagel |
| Drug Label | Clindagel (clindamycin phosphate gel) topical gel, 1%, a topical antibiotic, contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per gram in a gel vehicle consisting of carbomer 941, methylparaben, polyethylene g... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Gel |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Precision Dermat |
| 10 of 12 | |
|---|---|
| Drug Name | Clindamycin phosphate |
| PubMed Health | Clindamycin (Injection) |
| Drug Classes | Antibiotic, Antimalarial |
| Drug Label | Clindamycin Injection, USP, a water soluble ester of clindamycin and phosphoric acid, is a sterile solution for intramuscular or intravenous use.May contain sodium hydroxide and/or hydrochloric acid for pH adjustment. pH is 6.5 range 5.5to 7.0.Clin... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Lotion; Gel; Swab; Injectable; Cream; Aerosol, foam; Solution |
| Route | Topical; Injection; Vaginal |
| Strength | eq 1% base; 1%; eq 150mg base/ml; eq 2% base |
| Market Status | Prescription |
| Company | Wockhardt; Sagent Strides; Bedford; Fougera Pharms; Fresenius Kabi Usa; Hospira; Hikma Maple; Versapharm; Perrigo Uk Finco; Perrigo New York; Taro Pharm Inds; Fougera; G And W Labs |
| 11 of 12 | |
|---|---|
| Drug Name | Clindesse |
| Drug Label | CLEOCIN T Topical Solution and CLEOCIN T Topical Lotion contain clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. CLEOCIN T Topical Gel contains clindamycin phosphate, USP, at a concentration equivalent to... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Cream |
| Route | Vaginal |
| Strength | eq 2% base |
| Market Status | Prescription |
| Company | Lumara Health |
| 12 of 12 | |
|---|---|
| Drug Name | Clindets |
| Drug Label | Clindamycin phosphate, a lincosamide, is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. The chemical name for clindamycin phosphate is meth... |
| Active Ingredient | Clindamycin phosphate |
| Dosage Form | Swab |
| Route | Topical |
| Strength | eq 1% base |
| Market Status | Prescription |
| Company | Perrigo |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
API SUPPLIERS
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
Minakem is manufacturing small molecules APIs including corticosteroids
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13705
Submission : 1998-09-01
Status : Inactive
Type : II
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
Sigmak Lifesciences: Empowering Business with High-quality Ingredients.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13725
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32255
Submission : 2017-11-28
Status : Active
Type : II
NDC Package Code : 69132-003
Start Marketing Date : 2017-09-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-12
Pay. Date : 2013-01-23
DMF Number : 14412
Submission : 1999-09-23
Status : Active
Type : II
Certificate Number : R1-CEP 2000-097 - Rev 05
Issue Date : 2023-06-09
Type : Chemical
Substance Number : 996
Status : Valid
Registration Number : 226MF10069
Registrant's Address : Mallorca, 262, 3rd floor 08008 Barcelona Spain
Initial Date of Registration : 2014-03-11
Latest Date of Registration : --
NDC Package Code : 49711-0116
Start Marketing Date : 2009-10-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-11-30
Pay. Date : 2016-08-02
DMF Number : 17422
Submission : 2004-05-09
Status : Active
Type : II
Certificate Number : CEP 2003-060 - Rev 07
Issue Date : 2024-03-25
Type : Chemical
Substance Number : 996
Status : Valid
NDC Package Code : 39635-0001
Start Marketing Date : 2014-03-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13705
Submission : 1998-09-01
Status : Inactive
Type : II
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13725
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7359
Submission : 1988-02-29
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13413
Submission : 1998-09-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13499
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-03-06
Pay. Date : 2014-02-26
DMF Number : 12922
Submission : 1998-04-02
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-02-12
Pay. Date : 2013-01-23
DMF Number : 14412
Submission : 1999-09-23
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13082
Submission : 1998-07-08
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
Clindamycin phosphate, Albano plant
Certificate Number : R1-CEP 2006-033 - Rev 04
Status : Valid
Issue Date : 2022-09-01
Type : Chemical
Substance Number : 996
Certificate Number : R1-CEP 1999-025 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2007-06-15
Type : Chemical
Substance Number : 996
Certificate Number : R1-CEP 2005-033 - Rev 03
Status : Valid
Issue Date : 2023-01-17
Type : Chemical
Substance Number : 996
Clindamycin phosphate, Alternative process
Certificate Number : R1-CEP 2009-398 - Rev 04
Status : Valid
Issue Date : 2022-11-08
Type : Chemical
Substance Number : 996
Certificate Number : R0-CEP 2007-250 - Rev 01
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2009-07-07
Type : Chemical
Substance Number : 996
Certificate Number : R1-CEP 2000-097 - Rev 05
Status : Valid
Issue Date : 2023-06-09
Type : Chemical
Substance Number : 996
Clindamycin phosphate, Product code number 60960
Certificate Number : R0-CEP 2003-177 - Rev 01
Status : Expired
Issue Date : 2010-01-14
Type : Chemical
Substance Number : 996
Certificate Number : R1-CEP 2011-019 - Rev 01
Status : Valid
Issue Date : 2018-06-13
Type : Chemical
Substance Number : 996
Certificate Number : R1-CEP 2000-256 - Rev 05
Status : Withdrawn by Holder
Issue Date : 2019-01-31
Type : Chemical
Substance Number : 996
Certificate Number : R0-CEP 2007-299 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2012-03-08
Type : Chemical
Substance Number : 996
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...
Minakem is manufacturing small molecules APIs including corticosteroids
About the Company : Minakem Montreal is developing and manufacturing small molecules APIs and advanced intermediates, including corticosteroids. Following efficient processes and methodologies, our em...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
About the Company : Established in 2012, Nuray Chemicals Pvt Ltd is an API manufacturer for highly regulated markets. Its manufacturing facility with state-of-the-art R&D is located near Chennai in th...
Sigmak Lifesciences: Empowering Business with High-quality Ingredients.
About the Company : Sigmak Lifesciences is a leading contract manufacturer, merchant exporter, & distributor of pharmaceutical APIs & Fine Chemicals. We excel in Contract Manufacturing, covering a wid...
About the Company : We are a privately held Italian company founded in 1973. We are a fully integrated manufacturer of Cephalosporin, Carbapenem and Penicillin APIs as well as Finished Dosage Formula...
About the Company : Beijing Mesochem Technology Co. Ltd., which is located in the national economic and technological development area of Yizhuang, China, manufactures pharmaceutical chemicals, fine c...
About the Company : Fuan Pharmaceutical (Group) Co., Ltd. was established on February 25, 2004. The company is located in Chongqing Changshou Economic and Technological Development Zone, covering an a...
About the Company : HANGZHOU THINK CHEMICAL CO., LTD. (THINKCHEM) is an integrative corporation of trade, research and contract manufacture. With about ten years of business experiences on the marketi...
About the Company : Hanways Chempharm Co., Limited, the former one is Hubei Hanways Pharchem CO.,Limited, set up in 2009 in Wuhan, China. We are engaged in supplying APIs, pharmaceutical intermediate...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
Details:
CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) topical gel is a prescription medicine which is now available in US for the topical treatment of acne vulgaris in patients 12 years of age and older.
Lead Product(s): Clindamycin Phosphate,Adapalene,Benzoyl Peroxide
Therapeutic Area: Dermatology Product Name: Cabtreo
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 30, 2024
Lead Product(s) : Clindamycin Phosphate,Adapalene,Benzoyl Peroxide
Therapeutic Area : Dermatology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) topical gel is a prescription medicine which is now available in US for the topical treatment of acne vulgaris in patients 12 years of age and old...
Product Name : Cabtreo
Product Type : Small molecule
Upfront Cash : Not Applicable
January 30, 2024
Details:
Xaciato (clindamycin phosphate) vaginal gel 2% is a USFDA approved medication for the treatment of bacterial vaginosis (BV) in females 12 years of age and older.
Lead Product(s): Clindamycin Phosphate
Therapeutic Area: Infections and Infectious Diseases Product Name: Xaciato
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Daré Bioscience
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable January 10, 2024
Lead Product(s) : Clindamycin Phosphate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Daré Bioscience
Deal Size : Not Applicable
Deal Type : Not Applicable
Organon’s XACIATO (clindamycin phosphate) Vaginal Gel 2% Available Nationwide to Treat Bacterial...
Details : Xaciato (clindamycin phosphate) vaginal gel 2% is a USFDA approved medication for the treatment of bacterial vaginosis (BV) in females 12 years of age and older.
Product Name : Xaciato
Product Type : Small molecule
Upfront Cash : Not Applicable
January 10, 2024
Details:
Cabtreo (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel which is indicated for the treatment of Acne Vulgaris in patients twelve years of age and older.
Lead Product(s): Clindamycin Phosphate,Adapalene,Benzoyl Peroxide
Therapeutic Area: Dermatology Product Name: Cabtreo
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 20, 2023
Lead Product(s) : Clindamycin Phosphate,Adapalene,Benzoyl Peroxide
Therapeutic Area : Dermatology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Cabtreo (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel which is indicated for the treatment of Acne Vulgaris in patients twelve years of age and older.
Product Name : Cabtreo
Product Type : Small molecule
Upfront Cash : Not Applicable
October 20, 2023
Details:
Under the agreement, Daré has the global rights to Xaciato (clindamycin phosphate vaginal gel), an FDA-approved medication for the treatment of bacterial vaginosis (BV) in females 12 years of age and older.
Lead Product(s): Clindamycin Phosphate
Therapeutic Area: Infections and Infectious Diseases Product Name: Xaciato
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Organon
Deal Size: $192.8 million Upfront Cash: $10.0 million
Deal Type: Licensing Agreement October 16, 2023
Lead Product(s) : Clindamycin Phosphate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Organon
Deal Size : $192.8 million
Deal Type : Licensing Agreement
Daré Bioscience Announces Achievement of First Commercial Milestone Under License Agreement for X...
Details : Under the agreement, Daré has the global rights to Xaciato (clindamycin phosphate vaginal gel), an FDA-approved medication for the treatment of bacterial vaginosis (BV) in females 12 years of age and older.
Product Name : Xaciato
Product Type : Small molecule
Upfront Cash : $10.0 million
October 16, 2023
Details:
The net proceeds will be used the commercial launch of XACIATO (clindamycin phosphate) vaginal gel, a lincosamide antibacterial indicated for the treatment of bacterial vaginosis in female patients 12 years of age and older.
Lead Product(s): Clindamycin Phosphate
Therapeutic Area: Infections and Infectious Diseases Product Name: Xaciato
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Douglas Pharmaceuticals
Deal Size: $7.0 million Upfront Cash: Undisclosed
Deal Type: Financing September 05, 2023
Lead Product(s) : Clindamycin Phosphate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Douglas Pharmaceuticals
Deal Size : $7.0 million
Deal Type : Financing
Daré Bioscience Completes Previously Announced Equity Financing
Details : The net proceeds will be used the commercial launch of XACIATO (clindamycin phosphate) vaginal gel, a lincosamide antibacterial indicated for the treatment of bacterial vaginosis in female patients 12 years of ...
Product Name : Xaciato
Product Type : Small molecule
Upfront Cash : Undisclosed
September 05, 2023
Details:
Xaciato (clindamycin phosphate vaginal gel) inhibits bacterial protein synthesis by binding to the 23S RNA of the 50S subunit of the ribosome, FDA-approved treatment for females 12 and older with bacterial vaginosis.
Lead Product(s): Clindamycin Phosphate
Therapeutic Area: Infections and Infectious Diseases Product Name: Xaciato
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable July 05, 2023
Lead Product(s) : Clindamycin Phosphate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Daré Bioscience Provides Update on Activities to Support Commercial Launch of XACIATO™ (clindam...
Details : Xaciato (clindamycin phosphate vaginal gel) inhibits bacterial protein synthesis by binding to the 23S RNA of the 50S subunit of the ribosome, FDA-approved treatment for females 12 and older with bacterial vagi...
Product Name : Xaciato
Product Type : Small molecule
Upfront Cash : Not Applicable
July 05, 2023
Details:
Esmolol hydrochloride in sodium chloride injection is indicated for tachycardia. Company launched 8 new generic products, including clindamycin phosphate gel 1%, ipratropium bromide nasal sprays, and prednisolone sodium phosphate oral solution.
Lead Product(s): Clindamycin Phosphate
Therapeutic Area: Dermatology Product Name: Clindamycin Phosphate-Generic
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable December 20, 2022
Lead Product(s) : Clindamycin Phosphate
Therapeutic Area : Dermatology
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Esmolol hydrochloride in sodium chloride injection is indicated for tachycardia. Company launched 8 new generic products, including clindamycin phosphate gel 1%, ipratropium bromide nasal sprays, and prednisolo...
Product Name : Clindamycin Phosphate-Generic
Product Type : Small molecule
Upfront Cash : Not Applicable
December 20, 2022
Details:
Under the agreement, Organon licensed global rights to XACIATO (clindamycin phosphate vaginal gel, 2%), an FDA-approved medication for the treatment of bacterial vaginosis in females 12 years of age and older.
Lead Product(s): Clindamycin Phosphate
Therapeutic Area: Infections and Infectious Diseases Product Name: Xaciato
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Organon
Deal Size: $192.5 million Upfront Cash: $10.0 million
Deal Type: Licensing Agreement June 30, 2022
Lead Product(s) : Clindamycin Phosphate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Organon
Deal Size : $192.5 million
Deal Type : Licensing Agreement
Details : Under the agreement, Organon licensed global rights to XACIATO (clindamycin phosphate vaginal gel, 2%), an FDA-approved medication for the treatment of bacterial vaginosis in females 12 years of age and older.
Product Name : Xaciato
Product Type : Small molecule
Upfront Cash : $10.0 million
June 30, 2022
Details:
XACIATO is an FDA-approved medication for the treatment of bacterial vaginosis (BV) in females 12 years of age and older. XACIATO received both Qualified Infectious Disease Product (QIDP) and Fast Track designations from the FDA for the treatment of bacterial vaginosis.
Lead Product(s): Clindamycin Phosphate
Therapeutic Area: Infections and Infectious Diseases Product Name: Xaciato
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Daré Bioscience
Deal Size: $192.5 million Upfront Cash: $10.0 million
Deal Type: Licensing Agreement March 31, 2022
Lead Product(s) : Clindamycin Phosphate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Partner/Sponsor/Collaborator : Daré Bioscience
Deal Size : $192.5 million
Deal Type : Licensing Agreement
Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (cli...
Details : XACIATO is an FDA-approved medication for the treatment of bacterial vaginosis (BV) in females 12 years of age and older. XACIATO received both Qualified Infectious Disease Product (QIDP) and Fast Track designa...
Product Name : Xaciato
Product Type : Small molecule
Upfront Cash : $10.0 million
March 31, 2022
Details:
IDP-126 Gel, an investigational drug, efficacy and safety of a fixed-dose clindamycin 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for moderate-to-severe acne: randomized phase 2 and phase 3 studies of the first triple-combination drug.
Lead Product(s): Clindamycin Phosphate,Benzoyl Peroxide,Adapalene
Therapeutic Area: Dermatology Product Name: IDP-126
Highest Development Status: Phase IIIProduct Type: Small molecule
Partner/Sponsor/Collaborator: Bausch Health
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 22, 2022
Lead Product(s) : Clindamycin Phosphate,Benzoyl Peroxide,Adapalene
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Bausch Health
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : IDP-126 Gel, an investigational drug, efficacy and safety of a fixed-dose clindamycin 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for moderate-to-severe acne: randomized phase 2 and phase 3 studies of ...
Product Name : IDP-126
Product Type : Small molecule
Upfront Cash : Not Applicable
March 22, 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
SuanFarma is present in all origins: Natural, Chemical & Biotechnological.
CAS Number : 10025-87-3
End Use API : Clindamycin Phosphate
About The Company : Suanfarma founded in 1993, is a B2B life science partner committed to health & innovation by developing, manufacturing, & distributing high-quality APIs for the...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
Regulatory Info : Generic
Registration Country : India
Adapalene; Clindamycin Phosphate
Brand Name :
Dosage Form : Gel
Dosage Strength : 0.1%; 1%
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Adapalene; Clindamycin Phosphate
Dosage : Gel
Dosage Strength : 0.1%; 1%
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Tretinoin; Clindamycin Phosphate
Brand Name : Clinni-T
Dosage Form : Gel
Dosage Strength : 0.025%; 1%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Tretinoin; Clindamycin Phosphate
Dosage : Gel
Dosage Strength : 0.025%; 1%
Brand Name : Clinni-T
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 150mg/4ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Injection
Dosage Strength : 150mg/4ml
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : South Korea
Brand Name : Clinda Topical Solutio...
Dosage Form : Solution
Dosage Strength : 11.88MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Packaging :
Regulatory Info :
Dosage : Solution
Dosage Strength : 11.88MG/ML
Brand Name : Clinda Topical Solutio...
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info :
Registration Country : Turkey
Brand Name :
Dosage Form : Ampoule
Dosage Strength : 300MG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging :
Regulatory Info :
Dosage : Ampoule
Dosage Strength : 300MG/2ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name :
Dosage Form : Ampoule
Dosage Strength : 600MG/4ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging :
Regulatory Info :
Dosage : Ampoule
Dosage Strength : 600MG/4ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Turkey
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Gel
Dosage Strength : 1%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Gel
Dosage Strength : 1%
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Injection
Dosage Strength : 300MG
Packaging : 300mgx6vials
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Packaging : 300mgx6vials
Regulatory Info :
Dosage : Injection
Dosage Strength : 300MG
Brand Name :
Approval Date :
Application Number :
Registration Country : China
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Gel
Dosage Strength : 0.1G/5G
Packaging : 5G
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Packaging : 5G
Regulatory Info :
Dosage : Gel
Dosage Strength : 0.1G/5G
Brand Name :
Approval Date :
Application Number :
Registration Country : China
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION;INTRAVENOUS - EQ 300MG BASE...DOSAGE - SOLUTION;INTRAVENOUS - EQ 300MG BASE/50ML (EQ 6MG BASE/ML)
USFDA APPLICATION NUMBER - 208083
DOSAGE - SOLUTION;INTRAVENOUS - EQ 600MG BASE...DOSAGE - SOLUTION;INTRAVENOUS - EQ 600MG BASE/50ML (EQ 12MG BASE/ML)
USFDA APPLICATION NUMBER - 208083
DOSAGE - SOLUTION;INTRAVENOUS - EQ 900MG BASE...DOSAGE - SOLUTION;INTRAVENOUS - EQ 900MG BASE/50ML (EQ 18MG BASE/ML)
USFDA APPLICATION NUMBER - 208083
DOSAGE - INJECTABLE;INJECTION - EQ 150MG BASE...DOSAGE - INJECTABLE;INJECTION - EQ 150MG BASE/ML
USFDA APPLICATION NUMBER - 50441
DOSAGE - SOLUTION;TOPICAL - EQ 1% BASE **Fede...DOSAGE - SOLUTION;TOPICAL - EQ 1% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50537
DOSAGE - LOTION;TOPICAL - EQ 1% BASE
USFDA APPLICATION NUMBER - 50600
DOSAGE - GEL;TOPICAL - EQ 1% BASE
USFDA APPLICATION NUMBER - 50615
DOSAGE - GEL;TOPICAL - 5%;1.2%
USFDA APPLICATION NUMBER - 50741
DOSAGE - GEL;TOPICAL - 5%;EQ 1% BASE
USFDA APPLICATION NUMBER - 50756
DOSAGE - SUPPOSITORY;VAGINAL - 100MG
USFDA APPLICATION NUMBER - 50767
DOSAGE - GEL;TOPICAL - EQ 1% BASE
USFDA APPLICATION NUMBER - 50782
DOSAGE - CREAM;VAGINAL - EQ 2% BASE
USFDA APPLICATION NUMBER - 50793
DOSAGE - AEROSOL, FOAM;TOPICAL - 1% **Federal...DOSAGE - AEROSOL, FOAM;TOPICAL - 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 50801
DOSAGE - GEL;TOPICAL - 1.2%;0.025%
USFDA APPLICATION NUMBER - 50803
Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Jai Radhe Sales
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]BioSpectra
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
Dosage Form : Syrup
Grade : Oral and Topical
Application : Taste Masking
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Topical
Solubilizers
Parenteral
Thickeners and Stabilizers
Film Formers & Plasticizers
Emulsifying Agents
Fillers, Diluents & Binders
Co-Processed Excipients
Coating Systems & Additives
Direct Compression
Surfactant & Foaming Agents
Controlled & Modified Release
Lubricants & Glidants
Taste Masking
Granulation
Rheology Modifiers
API Stability Enhancers
Chewable & Orodispersible Aids
Soft Gelatin
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
Market Place
